Logo

array CGH

Researchers Explore Real-Time CNV Detection in Patient Samples With Nanopore Sequencing
Premium

Scientists from the University of Florence in Italy applied nanopore sequencing to effectively detect known copy number variants in a small cohort of patients.

Arcedi Biotech Introduces NIPT Analyzing DNA From Rare Fetal Cells in Maternal Blood
Premium

The company is positioning the blood-based test as an alternative to invasive chorionic villus sampling, the current standard in Denmark.

Array Genomics Sets Out to Build Business for Bladder Cancer Test
Premium

The British molecular diagnostics company received a CE-IVD mark for the assay, called BCA-1, in June, and launched the test in October.

Kidney Transplant Rejection Linked to New Mismatch Locus

A LIMS1 gene variant appeared to coincide with increased risk of allograft rejection in kidney transplant recipients.

Triple-Negative Breast Cancer Mutations, Subtypes Profiled in Chinese Patients

Genomic and transcriptomic data for almost 500 triple-negative breast cancer cases revealed four expression subtypes and suspected treatment targets.

Sep 11, 2018

Japanese Study Finds Shared CNVs in Schizophrenia, Autism

Jul 13, 2018

Copy Number Profiles Point to Possible Prognostic Alterations in Liver Cancer Metastases

May 21, 2018

Study Highlights HeLa Cell Heterogeneity
Premium

Mar 2, 2018

Mosaic Maternal Fragile Site Expansion Adds to List of Variants Causing False-Positive NIPT Results

Nov 13, 2017

Genomic Signatures Offer Insights Into Non-Invasive Bladder Cancer

Nov 1, 2017

Study Highlights Molecular Changes in Tumor-Neighboring Tissue in Breast Cancer Patients

Oct 30, 2017

Arcedi Biotech Readying Cell-Based NIPT for Commercialization as Clinical Studies Continue
Premium

Jul 19, 2017

NanoVelcro Microchips Can Capture Fetal Cells from Maternal Blood for Prenatal Genetic Testing
Premium

May 31, 2017

Sysmex to Acquire Oxford Gene Technology

Aug 28, 2015

Study Compares CGH Microarray Analysis to Karyotyping, FISH in Diagnosis of Hematological Cancer
Premium

Feb 3, 2015

For PGS Market Entry, Agilent Draws on Dubai IVF Clinic Partnership, New 16-Plex Array Format
Premium

Jan 8, 2015

CNV Analysis Unearths Compound Gene Mutations Behind Congenital Scoliosis

Dec 24, 2014

UK's Deciphering Developmental Disorders Study IDs 12 New Disease Genes by Genotype-driven Approach

Dec 2, 2014

Belgian Team Identifies Marker Associated with Triple Negative Breast Cancers Using Array CGH
Premium

Nov 10, 2014

In PGD Study, qPCR Largely Concordant with Array CGH, but May Yield Fewer False Positives
Premium

Jul 31, 2014

Study Links Subset of Rare Genomic Disorders to Low-level Somatic Mosaicism in Parents

Jul 30, 2014

Circulating Tumor Cells Seen in Subset of Glioblastoma Multiforme Brain Cancer Cases

Mar 19, 2014

Immune Gene Study Uncovers Cytokine Alterations Associated with Colorectal Cancer Progression

Feb 28, 2014

Exome Sequencing Study Narrows in on New Cushing's Syndrome Gene Culprit

Nov 12, 2013

Agilent, Baylor Collaborate on Customized CGH Microarrays

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.